2025-01-13 – Press Releases – www.prnewswire.com
MELBOURNE, Australia and INDIANAPOLIS, Jan. 13, 2025 /PRNewswire/ — Telix Pharmaceuticals Limited (ASX: TLX, Nasdaq: TLX, Telix, the Company) today provides an update on its commercial and operational performance for the quarter ended 31 December 2024 (Q4 2024). Sustained revenue growth…
